Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
SPECIAL ARTICLE
Lung cancer: Immunosurveillance, immunoediting or immunoepigenetics?
Pneumon 2005;18(3)
KEYWORDS
ABSTRACT
Lung cancer is amongst the most frequent and malignant of neoplasms. Its mortality rates place it first of all types of cancer with more than 1.000.000 deaths annually worldwide. It is characterized by a series of biological and clinical features that position it in the epicenter of current research efforts. To this end, it is noted that this cancer responds poorly to various immunotherapeutic interventions as opposed to other malignancies.
Share
RELATED ARTICLE
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
